Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women

QR Code

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women

The tolerability, safety, and disposition of dihydroartemisinin (DHA) and piperaquine (PQ) were assessed in 32 pregnant (second/third trimester) and 33 nonpregnant Papua New Guinean women randomized to adult treatment courses of DHA-PQ (three daily doses) or sulfadoxine-pyrimethamine (SP)-PQ (three...

Full description

Bibliographic Details
Main Authors:	Benjamin, J., Moore, B., Salman, S., Page-Sharp, Madhu, Tawat, S., Yadi, G., Lorry, L., Siba, P., Batty, Kevin, Robinson, L., Mueller, I., Davis, T.
Format:	Journal Article
Published:	American Society for Microbiology 2015
Online Access:	http://hdl.handle.net/20.500.11937/13840

Similar Items

PHARMACOKINETICS OF TRANSFER OF PIPERAQUINE INTO THE BREAST MILK OF PAPUA NEW GUINEAN MOTHERS
by: Moore, B., et al.
Published: (2015)

Effect of coadministered fat on the tolerability, safety and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria
by: Moore, Brioni, et al.
Published: (2014)

Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women
by: Moore, B., et al.
Published: (2016)

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria
by: Salman, S., et al.
Published: (2012)

Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers
by: Moore, B., et al.
Published: (2015)

Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women
by: Karunajeewa, H., et al.
Published: (2009)

Toxicology and pharmacokinetics of piperaquine in mice
by: Batty, Kevin, et al.
Published: (2008)

Investigation of reproductive toxicology in piperaquine in mice
by: Batty, Kevin, et al.
Published: (2010)

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria
by: Karunajeewa, H., et al.
Published: (2008)

Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model
by: Moore, Brioni, et al.
Published: (2008)

Optimal antimalarial dose regimens for sulfadoxine-pyrimethamine with or without azithromycin in pregnancy based on population pharmacokinetic modeling
by: Salman, S., et al.
Published: (2017)

Piperaquine pharmacodynamics and parasite viability in a murine malaria model
by: Moore, Broni, et al.
Published: (2009)

Electrocardiographic safety of repeated monthly dihydroartemisinin-piperaquine as a candidate for mass drug administration
by: Millat-Martínez, P., et al.
Published: (2018)

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
by: Salman, S., et al.
Published: (2011)

Pharmacokinetic Properties of Conventional and Double-Dose Sulfadoxine-Pyrimethamine Given as Intermittent Preventive Treatment in Infancy
by: Salman, S., et al.
Published: (2011)

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: Feasibility of abbreviated high-dose regimens for radical cure of vivax malaria
by: Moore, Brioni, et al.
Published: (2014)

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether
by: Manning, L., et al.
Published: (2011)

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria
by: Karl, S., et al.
Published: (2016)

Validation of a dried blood spot ceftriaxone assay in Papua New Guinean children with severe bacterial infections
by: Mukap, M., et al.
Published: (2018)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
by: Laman, M., et al.
Published: (2014)

Pharmacokinetics of dihydroartemisinin in a murine malaria model
by: Batty, Kevin, et al.
Published: (2008)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study
by: Laman, M., et al.
Published: (2015)

In vivo and molecular evaluation of artesunate+sulfadoxine-pyrimethamine efficacy for uncomplicated falciparum malaria in Tehama region, Yemen / Wahib Mohammed Mohsein Atroosh
by: Wahib Mohammed, Mohsein Atroosh
Published: (2017)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, M., et al.
Published: (2014)

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial
by: Pomat, William, et al.
Published: (2013)

Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
by: Moore, Brioni, et al.
Published: (2017)

Anti-inflammatory and antibacterial effects of kinos from Australian and Papua New Guinean Eucalyptus species
by: Mungkaje, Martha Yahimbu
Published: (2015)

Improving the Solubility and Bioavailability of Dihydroartemisinin by Solid Dispersions and Inclusion Complexes
by: Ansari, M., et al.
Published: (2011)

Development of a Papua New Guinean onshore carbonate reservoir: A comparative borehole image (FMI) and petrographic evaluation
by: Wilson, Moyra, et al.
Published: (2013)

Emerging possibilities and constraints to Papua New Guinean smallholder coffee producers entering the speciality coffee market
by: Murray-Prior, Roy, et al.
Published: (2007)

Solid Dispersions of Dihydroartemisinin in Polyvinylpyrrolidone
by: Ansari, M., et al.
Published: (2008)

Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants
by: Francis, Jacinta, et al.
Published: (2009)

Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin
by: Gibbons, Peter, et al.
Published: (2007)

An evaluation of patients’ adherence with hypoglycemic medications among Papua New Guineans with Type 2 Diabetes: Influencing factors
by: Pihau-Tulo, Stella, et al.
Published: (2014)

Plasmodium berghei: Parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model
by: Moore, Brioni, et al.
Published: (2008)

Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria
by: Patel, K., et al.
Published: (2013)

Dihydroartemisinin-cyclodextrin Complexation: Solubility and Stability
by: Ansari, M., et al.
Published: (2009)

Ertapenem for osteoarticular infections in obese patients: a pharmacokinetic study of plasma and bone concentrations
by: Chambers, J., et al.
Published: (2018)

Pharmacokinetics of Chloroquine and Monodesethylchloroquine in Pregnancy
by: Karunajeewa, H., et al.
Published: (2010)

A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
by: Karunajeewa, H., et al.
Published: (2008)